Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Full textbookMRCPMRCS

Endocrine physiology and feedback systems

Explain hormone synthesis, transport, receptor signalling, pulsatility and feedback, then use dynamic patterns to localise endocrine dysfunction without relying on isolated concentrations.

Saved on this device
Open the sections you need. The overview is shown first.
01Core principlesThe concepts and mechanisms needed to understand the subject.

Endocrine systems transmit information across distance while preserving specificity through receptors. Peptides and catecholamines are water soluble, circulate largely free and activate membrane receptors with rapid signalling and amplification. Steroids and thyroid hormones are lipid soluble, circulate substantially protein bound and influence intracellular receptors and gene expression, although rapid non-genomic effects also exist. Hormone concentration alone does not define effect: receptor density, affinity, downstream signalling, binding proteins, metabolism and tissue access all matter.

A typical axis uses hypothalamic releasing factors, pituitary trophic hormones and target-gland hormones. Negative feedback from the target hormone restrains upstream secretion. Primary target-gland failure therefore tends to combine low target hormone with high trophic drive; secondary or tertiary failure combines low target hormone with inappropriately low or normal upstream signal. Autonomous secretion produces a high target signal with suppression of upstream drive. These are patterns, not universal pairs: pulsatility, assay interference, exogenous hormones and severe illness can distort them.

Timing is biological information. Cortisol follows a circadian rhythm and responds to stress; growth hormone is pulsatile; reproductive hormones vary through developmental and cyclical states. A random value may miss peaks or troughs. Dynamic testing asks whether a reserve can be stimulated or autonomous secretion suppressed. A stimulation test gives an input and measures output over defined times; a suppression test applies a feedback-like signal and looks for appropriate fall. Protocol thresholds are assay and context dependent, so mechanism should guide interpretation but not replace current laboratory standards.

Endocrine feedback also governs water, calcium, energy and blood pressure. Osmoreceptors regulate vasopressin and thirst, while effective circulating volume can override osmotic signals. Parathyroid hormone integrates ionised calcium sensing with bone, kidney and vitamin-D effects. Insulin and glucagon coordinate fuel storage and mobilisation. Renin, angiotensin and aldosterone respond to renal perfusion, sodium delivery and sympathetic drive. Acute illness can alter several axes adaptively; drawing extensive hormone panels during instability can create apparent abnormalities that need recovery-state review.

Key points

  • Peptide hormones are synthesised as precursors, stored and released by exocytosis, whereas steroid hormones are synthesised from cholesterol and usually diffuse out as they are made.
  • Water-soluble hormones commonly signal through surface receptors and second messengers; lipid-soluble hormones often bind intracellular receptors that alter transcription.
  • Binding proteins increase total circulating hormone and buffer availability, while free hormone is usually the biologically active fraction sensed by feedback systems.
  • Negative feedback stabilises an axis: target-gland hormone suppresses hypothalamic and pituitary drive, so paired upstream and downstream measurements help localise failure.
  • Hormone secretion is pulsatile and circadian, and stress, sleep, meals, pregnancy, illness and medicines can alter a single measurement.
  • Dynamic tests perturb an axis with stimulation or suppression; interpretation depends on the question, protocol, assay, sampling times and pre-test context.
02Mechanisms and patternsImportant relationships and how to distinguish them.
Primary gland failure

Low target hormone with appropriately raised trophic drive suggests failure at the target organ when timing, assay and exogenous treatment are accounted for.

Central deficiency

Low target hormone with an upstream signal that is low or not appropriately raised points toward pituitary or hypothalamic dysfunction.

Autonomous secretion

Excess target-gland hormone with suppressed physiological drive suggests secretion escaping normal feedback, though exogenous exposure must also be considered.

Binding-protein change

Total hormone may change while free hormone and biological state remain stable, particularly during pregnancy, liver change or altered protein binding.

Receptor resistance

High hormone concentration can coexist with reduced biological effect and compensatory drive when receptor or post-receptor signalling is impaired.

Temporal variation

Pulse timing, circadian phase and recent physiological stress can make a correct result misleading if compared with the wrong reference conditions.

03Interpreting evidenceInformation, measurements and their limitations.
Reasoning sequence

Consider the information, its meaning and its limitations before deciding what follows.

  1. 01
    Paired-axis measurement
    Why
    Compare upstream drive with target-gland output.
    Interpretation and limitations
    Judge whether the trophic hormone is appropriate for the target level; reference ranges alone can hide an inappropriately normal result.
  2. 02
    Free and total hormone comparison
    Why
    Distinguish true endocrine change from altered binding proteins.
    Interpretation and limitations
    Assay method and binding state matter; a total concentration cannot always represent free biologically available hormone.
  3. 03
    Timed sampling
    Why
    Match collection to circadian, pulsatile or cycle-dependent physiology.
    Interpretation and limitations
    Document time, sleep, meals, stress and treatment; repeating under valid conditions may be more informative than adding unrelated tests.
  4. 04
    Stimulation test logic
    Why
    Assess secretory reserve after a defined input.
    Interpretation and limitations
    Confirm protocol, contraindications, baseline state, exact sampling and assay-specific thresholds; a poor response localises only within the tested axis context.
  5. 05
    Suppression test logic
    Why
    Assess whether secretion responds to an inhibitory signal.
    Interpretation and limitations
    Failure to suppress may support autonomy, but adherence, absorption, interacting medicines and stress can invalidate the perturbation.
  6. 06
    Assay-interference review
    Why
    Explain biochemical results that conflict sharply with physiology.
    Interpretation and limitations
    Consider biotin, heterophile antibodies, cross-reactivity and platform differences, and discuss discordance with the laboratory before escalating a false pattern.
04Applied reasoningWorked examples connecting principles to decisions.
01Worked exampleLocalise an endocrine axis abnormalityA model axis has repeatedly low target-gland free hormone and a trophic hormone concentration above its reference range, sampled under appropriate stable conditions without exogenous hormone.
  1. 1Start with the target hormone: repeated low free concentration indicates reduced circulating output rather than an isolated binding-protein change.
  2. 2Ask whether upstream drive is appropriate; the raised trophic hormone shows that feedback sensing and pituitary response are active.
  3. 3Localise the dominant dysfunction to the target gland because it fails to produce adequate hormone despite increased stimulation.
  4. 4The final pattern is primary target-gland failure, with the named gland and cause requiring axis-specific assessment.
  5. 5Verify by predicting the opposite central pattern: low target hormone with low or inappropriately normal trophic signal.
02Feedback reasoningPredict autonomous target secretionA target gland secretes hormone independently while hypothalamic and pituitary feedback pathways remain responsive.
  1. 1Predict rising circulating target hormone and increased receptor effect in responsive tissues.
  2. 2Apply negative feedback to hypothalamus and pituitary.
  3. 3Expect suppressed releasing and trophic hormones despite persistent target output.
  4. 4Check for exogenous hormone exposure because it can create a similar paired biochemical pattern.
03Dynamic-test reasoningInterpret failure of suppressionA suppression agent was given correctly and absorbed, sampling times were valid, and the measured hormone remains above the assay-specific expected suppressed range.
  1. 1Confirm the test was intended to reproduce an inhibitory signal within that axis.
  2. 2Exclude protocol and assay problems before assigning physiology.
  3. 3Interpret persistent secretion as evidence against normal suppressibility and in favour of autonomous or dysregulated output.
  4. 4Use complementary localisation testing rather than assuming the organ source from suppression failure alone.
05Checking understandingVerify the reasoning, revisit uncertainties and apply feedback.
  • Draw every axis with arrows for stimulation and feedback before predicting paired hormone concentrations.
  • Check whether the reported value is free, total, bound or calculated and whether binding proteins changed.
  • Match samples to biological timing and current illness rather than applying a universal static reference.
  • Review dynamic tests through indication, input, expected response, sampling and invalidating factors.
  • Use discordant clinical and biochemical patterns to trigger assay and exposure review instead of inventing a rare diagnosis immediately.
06Special situationsVariants, exceptions and circumstances that change the usual approach.

Normal can be inappropriate

A trophic hormone inside its population reference range may be abnormal when the target hormone is low and should have provoked a much larger response.

Feedback localises levels

Paired measurements are powerful because one concentration reports output and the other reports how the control system is responding to that output.

Hormone action can resist

Receptor or signalling defects can produce high circulating hormone alongside features of deficiency, with compensatory upstream stimulation.

Illness perturbs axes

Stress and systemic disease can alter secretion, binding and conversion, so testing context is part of the physiological interpretation.

Dynamic tests answer one question

A suppression or stimulation response can support function or autonomy but does not automatically establish anatomy or underlying cause.

07Common pitfallsFrequent interpretation and management errors.
  1. 01

    Diagnosing endocrine disease from one untimed result without considering pulses, circadian phase, stress or treatment.

  2. 02

    Using total hormone as a direct proxy for biological activity when binding protein concentration has changed.

  3. 03

    Calling an upstream value normal because it lies in range despite an abnormal target hormone that should stimulate it.

  4. 04

    Treating every failed dynamic test as biological when dosing, absorption, sampling or assay validity is uncertain.

  5. 05

    Assuming a paired biochemical pattern identifies a lesion location without considering exogenous hormone and receptor resistance.

Practice

Two practice questions

Question 1 of 20 correct
Applied basic sciencesOriginal SBA

Localising primary failure

Repeated stable samples show low free target-gland hormone and a trophic hormone above its reference range, with no exogenous hormone. What is the best localisation?

Sources and review status6 sources · checked 7 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 7 Sept 2026; clinical approval remains outstanding.

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom